Vaccitech plc Contracts & Agreements
24 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (3)
- Human Resources (3)
- Intellectual Property (4)
- Mergers & Acquisitions (3)
- Uncategorized (5)
- Service Agreemen (Filed With SEC on November 6, 2024)
- Funding Agreement by and between the Registrant, Coalition for Epidemic Preparedness Innovations and the University of Oxford, dated as of December 20, 2023 (Filed With SEC on March 20, 2024)
- Compensation Recovery Policy (Filed With SEC on November 9, 2023)
- Employment Agreement by and between Vaccitech Switzerland GmbH and Nadge Pelletier, effective February 1, 2023 (Filed With SEC on May 12, 2023)
- Form of Indemnification Agreement between the Registrant and each of its directors and officers (Filed With SEC on November 10, 2022)
- Service Agreement with Gemma Brown, effective September 15, 2022 (Filed With SEC on November 10, 2022)
- Registration Rights Agreement, dated August 9, 2022, by and among Vaccitech plc and the investors listed thereto (Filed With SEC on August 9, 2022)
- Amendment No. 2 to Agreement and Plan of Merger and Reorganization, dated May 9, 2022, by and between Vaccitech plc and Benjamin Eisler, as the Securityholder Agent (Filed With SEC on August 9, 2022)
- Registration Rights Agreement, dated March 28, 2022, by and among Vaccitech plc and Benjamin Eisler, as the Securityholder Agent (Filed With SEC on May 11, 2022)
- Description of Registrants Securities (Filed With SEC on March 25, 2022)
- Amendment No. 1 to Agreement and Plan of Merger and Reorganization, dated March 11, 2022, by and between Vaccitech plc and Benjamin Eisler, as Securityholder Agent (Filed With SEC on March 25, 2022)
- Agreement and Plan of Merger and Reorganization, dated December 9, 2021, by and among Vaccitech plc, VA Merger Sub 1 Inc., VA Merger Sub 2 Inc., Avidea Technologies Inc., and... (Filed With SEC on December 14, 2021)
- 2021 Employee Share Purchase Plan (to be adopted prior to the effectiveness of this registration statement) (Filed With SEC on April 26, 2021)
- 2021 Share Option and Incentive Plan and forms of award agreements thereunder (to be adopted prior to the effectiveness of this registration statement) (Filed With SEC on April 26, 2021)
- Form of Deposit Agreement (Filed With SEC on April 26, 2021)
- Form of Underwriting Agreement (Filed With SEC on April 26, 2021)
- EMI Option Scheme and form of award agreement thereunder (Filed With SEC on April 9, 2021)
- Form of Deed of Indemnity between the Registrant and each of its directors and officers (Filed With SEC on April 9, 2021)
- Clinical Trial and Option Agreement by and among Vaccitech Oncology Limited, Cancer Research Technology Limited, and Cancer Research UK, dated as of December 16, 2019 (Filed With SEC on April 9, 2021)
- License Agreement by and between the Registrant and Vaccitech Oncology Limited, dated as of November 14, 2018 (Filed With SEC on April 9, 2021)
- License Agreement by and among the Registrant, The Chancellor, Masters and Scholars of the University of Oxford and Oxford University Innovation Limited, dated as of September 27,... (Filed With SEC on April 9, 2021)
- Master Collaboration Agreement by and between the Registrant and CanSino Biologics, Inc., dated as of September 4, 2018 (Filed With SEC on April 9, 2021)
- License Agreement by and between the Registrant and Oxford University Innovation Limited, dated as of September 8, 2017 (Filed With SEC on April 9, 2021)
- License of Technology by and between the Registrant and Oxford University Innovation Limited, dated as of March 4, 2016, as amended on January 14, 2019 and as further amended... (Filed With SEC on April 9, 2021)
